Overview

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study

Status:
Completed
Trial end date:
2017-10-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess and analyze the safety, tolerability and PK/PD data following single ascending and multiple ascending doses of X842 in healthy subjects.
Phase:
Early Phase 1
Details
Lead Sponsor:
Cinclus Pharma AG
Treatments:
Omeprazole